Dr Stewart Washer
Stewart has 25 years of CEO and Board experience in medical and agrifood biotech companies. He is currently the Executive Director of Zelda Therapeutics Ltd (ASX:ZLD) in the medicinal cannabis space, Chairman of Orthocell Ltd (ASX:OCC), a regenerative medicine company, Founding Chairman and current Director of Cynata Therapeutics Ltd (ASX:CYP) who are developing global stem cell therapies and Chairman of Minomic International Ltd with a novel approach to cancer diagnosis and treatment. He is also a founder and consultant to AusCann Ltd (ASX:AC8), the largest medicinal cannabis company in Australia.
Stewart has previously worked in life science Fund Management with BioScience Managers in Australia and the Nestlé Fund Inventages.
Stewart has held a number of Board positions in the past, including Chairman of Hatchtech Pty Ltd that was sold in 2015 for A$279m and was a Director of iCeutica that was sold to a US Pharma. He was also a Senator with Murdoch University and was a Director of AusBiotech Ltd.
Mr Alan Liddle
Mr. Alan Liddle has 30 years of executive management experience primarily in the medical and biotechnology research sector encompassing immunology and bio-therapeutics for cancer and autoimmune diseases, cardiology and neuroplasticity. Alan founded and led two of Australia’s leading biomedical/biotechnology companies, Micromedical Pty Ltd and Immune Systems Therapeutics Ltd.
Mr Raymore Millard
Mr. Raymore Millard holds extensive experience in providing strategic advice to both listed and unlisted companies in Australia and overseas. He has assisted various companies from raising seed capital, through to their ultimate listing. He is similarly assisting Minomic.
Mr Xueliang Huang
Mr. Huang is a major shareholder in Minomic. He has investment experience in both Australia and China. He is also a director of Super New Generation Pty Limited.